The receptor for advanced glycation endproducts (RAGE) does not contribute to pathology in a mouse mesenteric ischemia/reperfusion-induced injury model
The receptor for advanced glycation endproducts (RAGE) can engage a diverse class of ligands and contribute to the immune and inflammatory response to infection and injury. It is known to be a pathogenic receptor in many inflammatory diseases, including ischemia/reperfusion (IR) injuries in several...
Main Authors: | Mike C.L. Wu, Timothy D. Gilmour, Susanna eMantovani, Trent M. Woodruff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00614/full |
Similar Items
-
Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review
by: Austin H. Nguyen, et al.
Published: (2017-01-01) -
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020-10-01) -
Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
by: Alexandra Eichhorst, et al.
Published: (2019-07-01) -
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
by: Ali H. El-Far, et al.
Published: (2020-05-01) -
The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
by: Wei Tian, et al.
Published: (2012-05-01)